NewsCoronavirus

Actions

Remdesivir has 'little or no effect' in treating severe COVID-19 cases, WHO says

Agency says 3 other drugs also have no effect
Remdesivir has 'little or no effect' in treating severe COVID-19 cases, WHO says
Posted
and last updated

GENEVA — The U.N. health agency says the world’s largest randomized trial of COVID-19 treatments found “conclusive evidence” that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has little or no effect on severe cases.

The World Health Organization has announced long-awaited results of its six-month “Solidarity Therapeutics Trial” that endeavored to see if existing drugs might have an effect on the coronavirus.

The study, which was not peer-reviewed, found that four treatments tested — remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon — had “ little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.”

Remdesivir was the only drug of the four that had not largely been ruled out as ineffective in fighting COVID-19.

,

Weather

Daily Forecast

View Hourly Forecast

Day

Conditions

HI / LO

Precip

Wednesday

07/02/2025

Clear

-° / 75°

0%

Thursday

07/03/2025

Clear

104° / 70°

0%

Friday

07/04/2025

Clear

95° / 64°

0%

Saturday

07/05/2025

Clear

96° / 67°

0%

Sunday

07/06/2025

Clear

99° / 70°

0%

Monday

07/07/2025

Clear

101° / 72°

0%

Tuesday

07/08/2025

Clear

103° / 73°

0%

Wednesday

07/09/2025

Clear

103° / 74°

0%